“Bringing the world into focus
through the lens of Scripture”









K-House Africa


Banking Details



 Africa news





The Rise Of Islam












Global Government
















 Kings High Way Briefing Packs







 In The News provided by Koinonia House

Monitor The Strategic Trends

Biotech & Global Pestilence Introduction:


The threat of germ warfare has brought to the forefront long-forgotten diseases like plague, anthrax, and smallpox. Recent television news programs have highlighted secret projects in the former Soviet Union to develop antibiotic-resistant strains of genetically engineered viruses and bacteria.





Human Nature


Ron Matsen





About available formats


What does it mean to be human? Philosophers, theologians, sociologists and psychologists have attempted to understand the nature of mankind for ages. Their conclusions often contradict each other which lead to confusion rather than clarification. Clearly Man is a very complicated social being. The Bible tells us that man is “fearfully and wonderfully made.”
  • How do we understand our makeup and does it make a difference?
  • What is the meaning of being “created in the image of God?”
  • What causes our natural responses and can we change this behaviour?

Join Ron Matsen from the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of our “Human Nature” and gives insight into the architecture and accountability of all mankind.

This briefing pack contains approx. 2 hours of teaching.

  • DVD discs
  • M4A files
  • PDF Notes file







CANCER  Awareness






Our Precious Daughter Penny

Penny has been the bravest and shining example the Lord could have chosen and will be a witness to the Glory of God and the faithfulness of His promises forever.

We give thanks to all who supported her with their prayers, may God pour out His everlasting Love over you forever.






We are humbled beyond words by the Glory of God's Grace.

We will be forever grateful for the the wonderful friends praying continuously for Penny and her family.



Biotech & Global Pestilence


Cancer News Headlines


Hallmarks of Cancer 1: Self-Sufficiency in Growth Signals


Linda Ronstadt - Desperado (Simple Dreams Tour ... - YouTube

► 3:46► 

With roots in the Los Angeles country and folk-rock scenes, Linda Ronstadt became one of the most popular ...


Linda Ronstadt & James Ingram - "Somewhere Out There"



Linda Ronstadt - Tracks Of My Tears




Linda Ronstadt - Long Long Time Linda Ronstadt




Treasury Comments..








Price R 179





Beginning of Wisdom



 Dr. Chuck Missler

“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.




Price R 179.00



The Gospel: The Message of Reconciliation


by Ron Matsen 




Price R 179.00





One of the last instructions given by Jesus to the Church was, “Go into all the world and preach the gospel.” (Mark 16:15)

The fact is most Christians don’t know how to share their faith effectively. Sadly, many of the people they know in the world today are wandering around, lost and without hope, having never heard the wonderful Message of Reconciliation.

How would you answer the question, “What must I do to be saved?”

What are the essential facts, demands and promises of the Gospel?

Why are we told to evangelize?

Join Ron Matsen in the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of “The Gospel – The Message of Reconciliation” and gives practical insight into how to share the essential doctrines of salvation.

This briefing pack contains 2 hours of teaching

© Copyright 2013




Disaster Management News from TerraDaily.com


Earth News, Earth Science, Energy Technology, Environment News















Price R599.00





·         Dr. Chuck Missler - The seven Myths of Eschatology, How to Avoid Deception, Know Your Calling.

·         Dr. Steve Elwart - What is the World Coming To? A Global Intelligence Update. 

·         Chris Corlett - On Education: Playgrounds, Politics and Parents.

·         Gary Stearman - New Insights on the Last Generation, Abraham and the Four Kings.

·         Joel Richardson - The Rise of Antichrist, Encouragement for the Last Days.

·         Dr. William Welty - The Validity of the State of Israel.

·         Chris Putnam - Astrobiology: The 'Science' With Nothing To Study, Who are the Immortals Driving Paranormal Paradigm Shift?

·         David McAlvany - A Legacy of Debt, International Families: Your Family Legacy From Finish to Start. 

·         Bob Cornuke - Traditions,Temples and Beyond, Alternate Location of the Crucifixion.

·         Joseph Farah - Restoration vs. the Spirit of Diotrephes.

·         Ron Matsen - Finding Peace in the Face of Peril. 

·         Lt. Col. Robert Maginnis, US Army (retired) - Never Submit.





Behold a Livid Horse: Emergent Diseases and Biochemical Warfare



PRICE R 249.00




Behold a Livid Horse:

 Emergent Diseases


Biochemical Warfare




by Dr. Chuck Missler



Dr. Chuck Missler explores these and other questions below concerning this climactic Fourth Horsemen and the unique role it plays in the End-Time Scenario:

•Why are previously conquered diseases now making a comeback?

•How real is the threat of biological terrorism?

•Why is it more dangerous than chemical terrorism?

•Was the AIDS virus deliberately designed? By whom? And why?

•Is there any truth behind an agenda to control (and reduce) the world’s population? By whom? And why?

•Who are the two riders associated with the Livid Horse? How do they differ?


This briefing pack contains 2 hours of teaching


Available in the following formats



•2 MP3 files

•1 PDF Notes file

•Colour, Full screen 16:9, Dolby Digital 2.0 stereo,



Diseases/Conditions News Headlines - Yahoo! News



Being overweight linked to eight more kinds of cancer

‎Today, ‎August ‎25, ‎2016, ‏‎3 hours agoGo to full article
Being overweight linked to eight more kinds of cancerBeing overweight can raise the likelihood of being diagnosed with cancers of the stomach and digestive tract, as well as certain brain and reproductive tumors, international researchers said Wednesday. A report in the New England Journal of Medicine adds eight more kinds of cancer to the list of those already known to be more likely among overweight people. In 2002, the World Health Organization's International Agency for Cancer on Research (IARC), based in France, said excess pounds could raise the risk of colon, esophagus, kidney, breast and uterine cancer.

Desperate and Distressed, Traumatized Syrians Go Online for Mental Health Care

‎Yesterday, ‎August ‎24, ‎2016, ‏‎11:55:07 PMGo to full article
Desperate and Distressed, Traumatized Syrians Go Online for Mental Health CareThe ongoing violence in Syria has taken a physical and mental toll on many, including one 9-year-old boy, who began to look up "ways to commit suicide" online, according to Dr. Hussam Jefee-Bahloul, who assisted with his care. Growing up, "Adam" (Jefee-Bahloul identifies the boy as Adam for his safety) had been irritable and nervous even before the crisis, but when the violence started, his mental health started to deteriorate further. "While being seen and treated with some medications, he developed adverse reactions and got more restless," Jefee-Bahloul said of Adam.

Over 14,000 women took Sanofi epilepsy drug despite fetus risk: ministry

‎Yesterday, ‎August ‎24, ‎2016, ‏‎7:18:28 PMGo to full article
More than 14,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 even though the risk of fetus malformation was known, according to a study released by France on Wednesday. Health Minister Marisol Touraine said in a statement that a second part of the study, yet to be released, would focus on the impact on children whose mothers took the drug. Its active ingredient is sodium valproate and it has been sold under different brand names.

Gum disease linked to heart disease

‎Tuesday, ‎August ‎23, ‎2016, ‏‎8:49:27 PMGo to full article
By Carolyn Crist (Reuters Health) - A report from The Netherlands adds to the evidence tying chronic gum disease to heart disease and stroke. In a study of more than 60,000 dental patients, those with gum disease were twice as likely to have had a heart attack, stroke or severe chest pain. Previous studies have linked periodontitis and clogged arteries, but this is the first to investigate the link in a group of people this large, the researchers say.

Heavy lifting by young workers linked to low back pain in midlife

‎Tuesday, ‎August ‎23, ‎2016, ‏‎5:03:47 PMGo to full article
By Linda Thrasybule (Reuters Health) - Young adults with jobs that involve heavy lifting and forceful movements might be at higher risk for back pain later in life, a study from Finland suggests. “When you’re young, you do things your own way, you muscle your way through it, but sooner or later, that behavior can cause problems,” said Michael Timko, a physical therapist and instructor at the University of Pittsburgh who was not involved with the study. “If we’re going to put a dent on the back pain issue, we should consider training younger people about basic body mechanics like how to lift and load and how to sit properly,” he told Reuters Health by phone.

Pfizer boosts cancer drug roster with $14 billion Medivation deal

‎Tuesday, ‎August ‎23, ‎2016, ‏‎12:39:52 AMGo to full article
The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S.Pfizer Inc , beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster. Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.4 percent at $34.84.

Pfizer spends $14B on Medivation in cancer fight

‎Monday, ‎August ‎22, ‎2016, ‏‎5:46:45 PMGo to full article
FILE - In this Monday, Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York. Pfizer is buying biopharmaceutical company Medivation in a deal valued at about $14 billion. Medivation Inc.’s stock soared more than 19 percent in Monday, Aug. 22, 2016 premarket trading. (AP Photo/Mark Lennihan, File)Pfizer will pay about $14 billion to buy cancer drug developer Medivation in a cash deal aimed at fortifying its hold in one of the hottest and most lucrative areas of medicine.

UN to provide 'material assistance' to Haiti cholera victims

‎Friday, ‎August ‎19, ‎2016, ‏‎8:47:43 PMGo to full article
FILE- In this Feb. 24, 2016, file photo, Dr. Vanessa Rouzier examines a child suffering cholera symptoms, as his mother watches, inside Haiti's first permanent cholera center, run by Gheskio Centers, in downtown Port-au-Prince, Haiti. The United Nations is saying for the first time on Thursday, Aug. 18, that it was involved in the introduction of cholera to Haiti and needs to do "much more" to end the suffering of those affected. (AP Photo/Dieu Nalio Chery, File)UNITED NATIONS (AP) — Secretary-General Ban Ki-moon is working on a package that would provide "material assistance" to cholera victims in Haiti, his spokesman said Friday, strongly indicating for the first time that hundreds of thousands of people affected will get financial help from the United Nations.

U.N. chief: Moral responsibility to help Haiti cholera victims

‎Friday, ‎August ‎19, ‎2016, ‏‎7:43:14 PMGo to full article
Patients rest on stretchers in the Cholera Treatment Center of Diquini in Port-au-Prince, HaitiBy Michelle Nichols UNITED NATIONS (Reuters) - United Nations Secretary-General Ban Ki-moon believes the world body has a moral responsibility to help Haiti's cholera victims and their families and is working to develop "material assistance" for them, his spokesman said on Friday. On Thursday, the U.N. made its first acknowledgment of its possible involvement in the introduction of cholera to Haiti six years ago that U.N. figures showed has killed more than 9,000 Haitians and infected 770,000.

U.S. judge upholds U.N. immunity in Haiti cholera case

‎Friday, ‎August ‎19, ‎2016, ‏‎4:56:24 PMGo to full article
A Haitian with symptoms of cholera is transported in a wheelbarrow in Port-au-PrinceBy Anastasia Moloney BOGOTA (Thomson Reuters Foundation) - A U.S. federal appeals court has upheld the United Nations' immunity from a damage claim filed by human rights lawyers on behalf of thousands of Haitians killed or sickened by a cholera epidemic they blame on U.N. peacekeepers. In a decision late on Thursday, the U.S. Second Circuit Court of Appeals in New York upheld a lower court's January 2015 dismissal of a lawsuit brought by lawyers seeking compensation and a public apology for 5,000 Haitian cholera victims. "We have considered all of plaintiffs' arguments on appeal and find them to be without merit," the U.S. appellate judges concluded.

Study links prenatal BPA exposure to anxiety and depression in boys

‎Friday, ‎August ‎19, ‎2016, ‏‎4:30:12 PMGo to full article
BPA was found to potentially affect boys' brains in utero, increasing the risk of depression in preadolescence.According to a new American study, boys exposed in utero to bisphenol A (BPA) -- a chemical commonly used in plastics -- could be at greater risk of developing symptoms of anxiety and depression at age 10 to 12. BPA is once again in the spotlight. Previous research has identified this synthetic estrogen as an endocrine disruptor linked to conditions such as asthma, anxiety, the early onset of puberty in girls, diabetes, obesity and heart disease in adults.

U.N. remarks on Haiti cholera a 'groundbreaking' step to justice, say lawyers

‎Thursday, ‎August ‎18, ‎2016, ‏‎8:17:04 PMGo to full article
By Anastasia Moloney BOGOTA (Thomson Reuters Foundation) - Lawyers seeking compensation for Haitians killed or sickened by cholera that they blame on United Nations peacekeepers said the U.N.'s admission on Thursday of its possible involvement in the outbreak was a breakthrough in their legal battle. Human rights lawyers from the Boston-based Institute for Justice and Democracy in Haiti (IJDH), filed a lawsuit in November 2011 against the United Nations demanding a public apology and compensation on behalf of 5,000 cholera victims.

Aid agencies race to contain cholera outbreak in Central African Republic

‎Thursday, ‎August ‎18, ‎2016, ‏‎5:54:37 PMGo to full article
By Kieran Guilbert DAKAR (Thomson Reuters Foundation) - Aid agencies in the Central African Republic said on Thursday they were racing to prevent the first outbreak of cholera in five years from spreading across the conflict-stricken country. The outbreak, which was declared last week, started in the southern Kemo prefecture before spreading to the capital Bangui, and has infected more than 150 people and killed at least 18 people to date, according to the latest government figures. Medical charity Médecins Sans Frontières (MSF) has opened a cholera treatment center in Bangui, and the International Organization for Migration (IOM) is supporting an awareness-raising campaign along the country's entire southern border.

Haiti cholera victims welcome UN recognizing role in outbreak

‎Thursday, ‎August ‎18, ‎2016, ‏‎5:51:48 PMGo to full article
Cholera patients being treated at the Cholera Treatment Center in the Carrefour area of Port-au-Prince,Haiti on December 10, 2014Port-au-Prince (AFP) - The United Nations' belated acknowledgement it played a role in a cholera epidemic in Haiti that has killed nearly 10,000 people was hailed by victims' advocates Thursday as vindication of their efforts to hold the world body accountable. UN Secretary-General Ban Ki-moon's deputy spokesman Farhan Haq promised a "significant new set of UN actions" to respond to the crisis, following a confidential report sent to the UN chief that was critical of the world body's actions. Draft language of the report, prepared by New York University law professor Philip Alston, who serves as a special rapporteur advising the UN on human rights issues, stated that the epidemic "would not have broken out but for the actions of the United Nations," according to The New York Times.

Thyroid cancer 'epidemic' down to overdiagnosis: study

‎Thursday, ‎August ‎18, ‎2016, ‏‎5:48:39 PMGo to full article
A woman undergoes a thyroid test at the military hospital in Neder-Over-Heembeek near Brussels on March 21, 2011A reported epidemic of thyroid cancer in rich countries is in fact mainly due to overdiagnosis driven by new technologies, the UN's cancer research agency said Thursday. Up to 90 percent of the thyroid cancer cases diagnosed in recent decades are, instead, tumours that are "very unlikely" to cause any symptoms at all, let alone death, according to findings published in The New England Journal of Medicine. Starting in the 1980s, the highest rates of overdiagnosis occurred in the US, Italy and France, they found.

More evidence ties insurance coverage to cancer survival

‎Wednesday, ‎August ‎17, ‎2016, ‏‎10:39:03 PMGo to full article
By Kathryn Doyle (Reuters Health) - In two new studies, U.S. cancer patients who are uninsured or have government-sponsored Medicaid insurance for the poor tend to be diagnosed later, receive less optimal treatment and survive for a shorter time than people with private health insurance. In one study of testicular germ cell cancer, which usually afflicts young men, 10 percent of patients were uninsured and 13 percent had Medicaid. “The thought is, and the data support, that patients are presenting with more advanced disease if they don’t have insurance,” senior author Christopher Sweeney of the Dana-Farber Cancer Institute in Boston told Reuters Health.

Study: Catalog of DNA variations helps find roots of disease

‎Wednesday, ‎August ‎17, ‎2016, ‏‎8:50:48 PMGo to full article
NEW YORK (AP) — A huge catalog of human DNA is helping researchers find tiny glitches that cause disease, in part by pointing out some false leads.

Exclusive: Merck enters race for cancer drugmaker Medivation - sources

‎Wednesday, ‎August ‎17, ‎2016, ‏‎7:49:40 PMGo to full article
The logo of Merck is pictured in this illustration photograph in Cardiff, CaliforniaBy Carl O'Donnell and Greg Roumeliotis (Reuters) - Merck & Co Inc is one of at least five pharmaceutical companies that submitted indications of interest in buying U.S. cancer drug company Medivation Inc earlier this month, according to people familiar with the matter. The strong interest in Medivation illustrates how demand for new cancer treatments, which can possibly add years to patients' lives, could mean billions of dollars in revenue to the companies that own them. Sanofi SA, Pfizer Inc, Celgene Corp and Gilead Sciences Inc also put forward expressions of interest, the sources said.

Study links childhood celiac disease to season and region of birth

‎Wednesday, ‎August ‎17, ‎2016, ‏‎6:44:25 PMGo to full article
Children born in spring are likely to be first exposed to gluten in the winter months, when seasonal viruses can damage gut flora.A Swedish study, published in the journal "Archives of Disease in Childhood," has found that children who develop gluten intolerance -- known as celiac disease -- are mostly girls, born in springtime and in the south of the country. Swedish researchers followed two million children born in Sweden between 1991 and 2009 up to the age of 15. Celiac disease is characterized by intolerance to gluten, a protein found in wheat, rye and barley.

Montreal concert aims to end AIDS, malaria and TB

‎Tuesday, ‎August ‎16, ‎2016, ‏‎10:05:14 PMGo to full article
Usher will headline a free concert for the advocacy group Global Citizen in MontrealUS R&B star Usher and Canadian indie rock groups Metric and Half Moon Run will headline a free concert in Montreal next month aimed at ending AIDS, malaria and tuberculosis. Advocacy group Global Citizen, the concert sponsor, said the September 17 show would be held at the city's Bell Centre a day after an international donor conference to raise money for the fight against the epidemics. Global Citizen said that some 10,000 tickets will be distributed to anyone who has helped in the fight by signing a petition or writing to a lawmaker to urge them to support the fund.

Can season and place of birth influence celiac disease risk?

‎Tuesday, ‎August ‎16, ‎2016, ‏‎8:35:46 PMGo to full article
A halo is seen around the sun in StockholmBy Lisa Rapaport (Reuters Health) - Winter babies and people born in places with shorter days and less sunlight might have a lower risk of developing celiac disease than peers born in warmer regions or seasons, a Swedish study suggests. About one in 100 people have celiac disease, an autoimmune disorder that damages the small intestine and interferes with the absorption of nutrients from food. People with celiac disease can't tolerate gluten, a protein in wheat, rye and barley.

Lack of stores with fresh foods linked to signs of early heart disease

‎Monday, ‎August ‎15, ‎2016, ‏‎11:09:15 PMGo to full article
By Kathryn Doyle (Reuters Health) - Living in poor neighborhoods has been linked to increased heart risk, and a new U.S. study suggests the lack of access to fresh, healthy foods may be to blame. “Previous studies have found relationships between neighborhood characteristics and cardiovascular disease,” said lead author Jeffrey Wing of Grand Valley State University in Grand Rapids, Michigan. “Finding that the density of healthy food stores was the only factor among those tested that consistently was related to slowing the progression of coronary calcium build-up was interesting in that we didn’t see the same relation with other neighborhood features,” like recreation centers, Wing told Reuters Health by email.

Heart disease epidemic will rise in China: study

‎Monday, ‎August ‎15, ‎2016, ‏‎8:11:51 PMGo to full article
Heart disease has been on the rise in China over the past 20 years, with more and more people experiencing high blood pressure, high cholesterol, high blood glucose, being overweight, smoking and lack of exerciseChina is facing an epidemic of heart disease brought on by a shift toward the Western lifestyle, and researchers said Monday the trend shows no sign of slowing down. The findings in the August 15 edition of the Journal of the American College of Cardiology are based on the first large study of its kind to analyze a range of risk factors in China over multiple decades. Heart disease has been on the rise in China over the past 20 years, with more and more people experiencing high blood pressure, high cholesterol, high blood glucose, being overweight, smoking and lack of exercise.

Delaware court backs UCB drug patent, shares jump

‎Monday, ‎August ‎15, ‎2016, ‏‎10:03:18 AMGo to full article
(Reuters) - A ruling by the Delaware District Court in the United States upholding the validity of UCB's patent for epilepsy drug Vimpat sent shares in the Belgian pharmaceutical firm up more than 7 percent on Monday. Sales of the drug totaled 679 million euros ($759 million) last year, of which about three quarters were in the United States. (Reporting by Wout Vergauwen; editing by Jason Neely)

Culture gap can make diabetes diet harder

‎Friday, ‎August ‎12, ‎2016, ‏‎6:26:17 PMGo to full article
A person receives a test for diabetes during Care Harbor LA free medical clinic in Los AngelesBy Lisa Rapaport (Reuters Health) - Patients with diabetes must work hard every day to count the carbs they consume, to avoid dangerous spikes or dips in blood sugar. Learning how to do it can be close to impossible, though, when language and cultural barriers make it difficult for doctors to understand what patients typically eat, a case report in Lancet Diabetes and Endocrinology suggests. “Carbohydrate counting is critical for accurate management of diabetes,” said co-author Dr. Sumana Narasimhan, a pediatric endocrinologist at Cleveland Clinic Children’s in Ohio.

Sleep apnea may worsen liver disease for obese teens

‎Thursday, ‎August ‎11, ‎2016, ‏‎8:44:59 PMGo to full article
By Kathryn Doyle (Reuters Health) - For teens with non-alcoholic fatty liver disease (NAFLD), breathing disruptions during sleep may worsen scarring in the liver, according to a new study. Researchers found that among obese adolescents with NAFLD, those with the most severe liver disease also had the most severe sleep disordered breathing that caused them to experience periods of low oxygen at night. “This really focuses on the role of oxidative stress both systemically and specifically in the liver as a driving factor of fibrosis and liver disease getting worse,” said lead investigator Dr. Shikha Sundaram of the Children's Hospital Colorado and the University of Colorado School of Medicine.

Mosquito traps laced with human scent help fight malaria

‎Thursday, ‎August ‎11, ‎2016, ‏‎6:37:15 PMGo to full article
Dutch and Kenyan scientists have been working on a mosquito trap which uses human odor to attract the malaria vector.Dutch and Kenyan scientists have designed a unique mosquito trap which uses human odour to attract the malaria-carrying insects, helping cut the number of cases dramatically, researchers said Wednesday. A three-year study in Kenya found the special traps baited with synthetic smell helped to catch 70 percent of the local malaria mosquito population, and led to a 30 percent drop in cases in households using the devices. "The odour-baited trap may also offer a solution to diseases like dengue fever and the Zika virus," Wageningen University in The Netherlands, which led the research, said in a statement.

Insomnia, sleep apnea tied to risk of second stroke

‎Wednesday, ‎August ‎10, ‎2016, ‏‎6:13:33 PMGo to full article
By Kathryn Doyle (Reuters Health) - People with sleep disorders like sleep apnea, insomnia or restless leg syndrome may have a poorer recovery after a stroke and higher risk of a second stroke, according to a review of existing research. The authors recommend screening for these sleep disorders among people who have had a stroke or mini-stroke. “We have been aware in neurology for a couple of years already that breathing disturbances are a risk factor for stroke,” said coauthor Dr. Dirk M. Hermann of University Hospital Essen in Essen, Germany.

Mosquito traps laced with human scent help fight malaria

‎Wednesday, ‎August ‎10, ‎2016, ‏‎5:36:14 PMGo to full article
Both dengue and Zika are caused by parasites carried by a different kind of mosquito to the malaria-bearing one, but which is also attracted by human smellDutch and Kenyan scientists have designed a unique mosquito trap which uses human odour to attract the malaria-carrying insects, helping cut the number of cases dramatically, researchers said Wednesday. A three-year study in Kenya found the special traps baited with synthetic smell helped to catch 70 percent of the local malaria mosquito population, and led to a 30 percent drop in cases in households using the devices. "The odour-baited trap may also offer a solution to diseases like dengue fever and the Zika virus," Wageningen University in The Netherlands, which led the research, said in a statement.

Lilly breast cancer drug stumbles, but trial continues

‎Wednesday, ‎August ‎10, ‎2016, ‏‎4:01:58 PMGo to full article
(Reuters) - U.S. drugmaker Eli Lilly and Co on Wednesday said it would continue a late-stage trial of its experimental breast cancer drug in combination with a widely used treatment even though an independent panel determined the combination therapy failed to meet its interim effectiveness goal. Leerink analyst Seamus Fernandez said continuation of the study, called Monarch 2, would allow Lilly to better understand abemaciclib, which is also being tested in a variety of other trials. The Monarch 2 study included 669 patients who had previously failed to benefit from anti-estrogen treatment for metastatic breast cancer.

Cargill stops using human antibiotic to prevent disease in turkeys

‎Wednesday, ‎August ‎10, ‎2016, ‏‎2:14:02 AMGo to full article
By Tom Polansek CHICAGO (Reuters) - U.S. meat processor Cargill Inc [CARG.UL] has stopped using an important antibiotic for people to prevent disease in most of its turkeys, the company said on Tuesday, the latest food maker to drop the drug over concerns about the impact on human medicine. Cargill has not used the drug, gentamicin, to prevent disease in turkeys that supply its two biggest brands, Honeysuckle White and Shady Brook Farms, since Aug. 1, the company said.

How much exercise will lower chronic disease risk?

‎Wednesday, ‎August ‎10, ‎2016, ‏‎1:02:14 AMGo to full article
The daily dose of physical exertion required to lower the risk of diabetes, stroke, heart disease, and both breast and bowel cancer by at least 20 percent, is several times the mininum recommended by the World Health Organization, researchers foundThe daily dose of activity needed to lower the risk of diabetes, stroke and heart disease by at least 20 percent is several times the minimum recommended by the World Health Organization, researchers said Wednesday. The same applies to breast and bowel cancer, they reported in a study reviewing 35 years of research on the link between physical exertion -- whether gardening or long-distance running -- and five chronic diseases. The benefits of exercise are well known and beyond dispute.

Thousands of women took Sanofi epilepsy drug despite risk to fetuses: media

‎Tuesday, ‎August ‎9, ‎2016, ‏‎9:27:20 PMGo to full article
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in ParisMore than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine. The ministry confirmed in a statement that a study was done by national drug agency ANSM and health insurance agency CNAMTS but added that it had not been hidden from families and that a first part of the study would be presented on August 24. Sanofi said the company was not aware of the data in the study and could not comment on it.

Cancer Patients Without Insurance Had Higher Death Rate, Studies Find

‎Tuesday, ‎August ‎9, ‎2016, ‏‎8:41:00 PMGo to full article
Cancer Patients Without Insurance Had Higher Death Rate, Studies FindThe importance of health insurance for cancer patients was again made clear in two new studies, which found that those with the disease had an increased risk of dying from it when they lacked health coverage. Both studies highlighted how preventive care, which people with health insurance receive more often, can affect survival rates for cancer patients. "As much as we are making advances in understanding biology and improving treatment for these cancers, early diagnosis and early management is still key and far more important, as this can cure patients," said Dr. Christopher Sweeney, the senior physician at the Dana-Farber Cancer Institute and a co-author of a study examining how medical coverage affected outcomes among testicular cancer patients.

After age 40, volunteering linked to enhanced mental health

‎Tuesday, ‎August ‎9, ‎2016, ‏‎6:58:21 PMGo to full article
By Kathryn Doyle (Reuters Health) - Volunteer work may be good for your mental wellbeing, but only after age 40, according to a new study. “There is a general consensus that volunteering is beneficial to everyone regardless of the age,” said lead author Dr. Faiza Tabassum of Southampton Statistical Sciences Research Institute at the University of Southampton in the UK. “However, our study has shown volunteering may be more strongly associated with mental well-being at some points of the life-course than others,” she told Reuters Health by email.

Eisai: FDA confirms enough data to move Alzheimer's drug to Phase III studies

‎Tuesday, ‎August ‎9, ‎2016, ‏‎9:08:11 AMGo to full article
Japan's Eisai Co said on Tuesday the U.S. Food and Drug Administration had confirmed that there was sufficient data to start Phase III studies of a drug it is co-developing to treat early Alzheimer's disease. The investigational oral beta-secretase cleaving enzyme (BACE) inhibitor E2609 was discovered by Eisai and is being jointly developed with Massachusetts-based Biogen Inc, Eisai said in a statement. Following the discussion with the FDA on the Phase III clinical study designs, Eisai and Biogen plan to have similar discussions with regulatory authorities in Japan and the European Union, Eisai said.

AstraZeneca drug selumetinib fails in lung cancer study

‎Tuesday, ‎August ‎9, ‎2016, ‏‎8:44:49 AMGo to full article
A sign is seen at an AstraZeneca site in MacclesfieldAstraZeneca's cancer drug pipeline suffered a setback on Tuesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for lung cancer. Hopes for the medicine had already been reduced after it failed in another study for treating a rare cancer of the eye in July 2015, although it may still have a role in a type of thyroid cancer and in cancers growing along nerve tissue. Selumetinib is viewed as less important than AstraZeneca's recently launched cancer drugs Tagrisso and Lynparza, and its closely watched experimental product durvalumab.

Mesoblast cell treatment shows promise in rheumatoid arthritis -study

‎Tuesday, ‎August ‎9, ‎2016, ‏‎12:47:00 AMGo to full article
(Reuters) - Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial. Treatment with the Australian company's mesenchymal precursor cell (MPC) product, MPC-300-IV, was deemed well tolerated with no serious side effects or infusion-related adverse events in the 48-patient, 12-week Phase II study, the company said. Among patients previously treated with at least one biologic drug, the common measure of 20 percent relief of signs and symptoms of the arthritis, known as ACR20, was achieved by 55 percent of those who received an infusion of 2 million cells per kilogram of weight.

Air pollution tied to shorter survival with lung cancer

‎Monday, ‎August ‎8, ‎2016, ‏‎8:01:54 PMGo to full article
A truck engine is tested for pollution near the Mexican-U.S. border in Otay Mesa, CaliforniaBy Lisa Rapaport (Reuters Health) - Exposure to air pollution has long been associated with an increased risk of lung cancer, and a new study suggests it might also be tied to a faster death from the disease. Researchers examined cancer registry data on more than 350,000 people diagnosed with lung cancer in California and found patients who lived in communities with higher than average levels of air pollution typically died sooner than their peers who lived in places with cleaner air. Patients with lung cancer may be a new subgroup of people susceptible to the health impacts of air pollution, since exposures after diagnosis may impact how long they live, said lead study author Sandrah Eckel, a researcher at the University of Southern California in Los Angeles.

One new drug for three deadly tropical diseases

‎Monday, ‎August ‎8, ‎2016, ‏‎5:38:30 PMGo to full article
Three Afghan children infected with leishmaniasis sit on a hospital bed at the Maywan Hospital in Kabul on May 5, 2002Collectively, these so-called "neglected tropical diseases" affect tens of millions of people and claim more than 50,000 lives each year. Chagas, sleeping sickness and leishmaniasis are caused by infection from parasites sharing a similar genetic profile. "It's a breakthrough in our understanding of the parasites that cause the three diseases, potentially allowing them to be cured," said Jeremy Mottram, a professor at the Centre for Immunology and Infection at the University of York in England, and co-author of the study.

Compound found to treat three parasitic tropical diseases

‎Monday, ‎August ‎8, ‎2016, ‏‎5:01:49 PMGo to full article
Scientists have found a single class of drugs that can kill the parasites responsible for three tropical diseases that affect millions in Africa, Asia and Latin America - Chagas disease, leishmaniasis and sleeping sickness. In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests. This provides a strong starting point for developing new drugs to replace existing treatments that are expensive, sometimes not very effective, and can also have side effects.

Novartis asthma pill shows promise in small trial

‎Saturday, ‎August ‎6, ‎2016, ‏‎10:38:26 AMGo to full article
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in BaselThe first new asthma pill in decades has produced promising results in a small clinical trial, potentially paving the way for another treatment option for patients by the end of the decade. Fevipiprant, which is being developed by Novartis, reduced a biological marker of asthma nearly five-fold in the 12-week trial involving 61 patients, researchers said on Saturday. Larger and longer studies are now needed to prove that the twice-daily pill can also reduce severe asthma attacks, known as exacerbations.

Bristol-Myers' Opdivo fails lung cancer trial; shares plunge

‎Friday, ‎August ‎5, ‎2016, ‏‎9:19:01 PMGo to full article
Bristol-Myers Squibb Co said its blockbuster Opdivo immunotherapy failed to slow progression of symptoms in previously untreated patients with advanced lung cancer, a major setback expected to benefit Merck & Co's rival medicine. Shares of Merck gained 8.7 percent to $62.89. "This is the worst-case scenario" for Opdivo and Bristol-Myers, Leerink analyst Seamus Fernandez said in a research note.

Scientists rehash evidence on sunscreen and skin cancer

‎Thursday, ‎August ‎4, ‎2016, ‏‎10:37:37 PMGo to full article
Holidaymakers and tourists sunbathe on the beach on a hot summer day in NiceBy Lisa Rapaport (Reuters Health) - There isn’t much evidence to conclusively prove that daily sunscreen use can prevent most skin cancers, a research review concludes. It just means it’s unethical to do experiments testing the effectiveness of sunscreen by randomly assigning some people to use it and others to skip it. “Lack of high quality experimental evidence should not be equated with evidence that such interventions are ineffective and it is important that patients and consumers do not stop protecting their skin until better quality evidence emerges,” lead authors Dr. Ingrid Arevalo-Rodriguez and Dr. Guillermo Sanchez of the Instituto de Evaluacion Technoloica en Salud in Bogota, Colombia told Reuters Health by email.

Why kids on traditional Amish farms don't get asthma

‎Thursday, ‎August ‎4, ‎2016, ‏‎4:04:26 PMGo to full article
Why kids on traditional Amish farms don't get asthmaChildren who grow up on traditional Amish farms in the United States are largely protected from asthma because their immune systems are bolstered by close contact with farm animals' microbes, researchers said Wednesday. The study in the August 4 edition of the New England Journal of Medicine compared two similar communities -- the Amish of Indiana and the Hutterites of South Dakota -- which have different methods of farming.

Women's risk factors for heart disease and stroke increase before menopause finds new study

‎Thursday, ‎August ‎4, ‎2016, ‏‎2:52:49 PMGo to full article
Women's risk factors for heart disease and stroke increase before menopause finds new studyNew US research has found that key risk factors for heart disease, diabetes and stroke appear to increase more rapidly in the years leading up to menopause. Published in the Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association, the study contradicts previous research that suggests the risk factors increase in the years after, not before, menopause.

At least 30 children dead in Myanmar from unknown disease

‎Thursday, ‎August ‎4, ‎2016, ‏‎10:46:54 AMGo to full article
YANGON, Myanmar (AP) — At least 30 children have died in northwestern Myanmar since mid-June from an unknown disease that causes breathing difficulty, officials said Thursday.

Can house dust explain why Amish protected from asthma?

‎Wednesday, ‎August ‎3, ‎2016, ‏‎11:08:59 PMGo to full article
In this April 9, 2013 photo, an Amish girl chases a cow from the outfield during a baseball game in Bergholz, Ohio. A study published Wednesday, Aug. 3, 2015 explored reasons why asthma is so uncommon among Amish communities, where children play barefoot in dairy barns and farm fields, while indoor pets are taboo. Early and frequent exposure to farming microbes might boost Amish children’s disease-fighting immune system, the study suggests. (AP Photo/Scott R. Galvin)CHICAGO (AP) — Forget Fluffy and Fido. Bessie the cow just might make a healthier pet.

Risk of diabetes and heart disease may spike before menopause

‎Wednesday, ‎August ‎3, ‎2016, ‏‎10:10:21 PMGo to full article
By Lisa Rapaport (Reuters Health) - Women may be at greater risk for developing diabetes, heart disease and stroke in the years before menopause, rather than afterward, a U.S. study suggests. “This may mean that the higher cardiovascular risk seen among post-menopausal women could be related to changes in that time before menopause and less so to the changes after menopause has occurred,” said lead study author Dr. Mark DeBoer, a researcher at University of Virginia School of Medicine in Charlottesville. While the reasons for this are unclear, the findings suggest that women may need to pay especially close attention to cardiovascular risk factors in the years leading up to menopause and consider lifestyle changes like improved diet and exercise habits that can make problems like diabetes and heart disease less likely, DeBoer added by email.

CVS drops Sanofi's diabetes drugs for biosimilars

‎Wednesday, ‎August ‎3, ‎2016, ‏‎3:17:04 PMGo to full article
A person walks by a CVS Pharmacy store in PasadenaBy Matthias Blamont PARIS (Reuters) - U.S. pharmacy benefit manager CVS will drop Sanofi's main insulin drug Lantus from the list of medicines it reimburses on behalf of health insurers, dealing a blow to the French drugmaker's key diabetes business. CVS said it would switch instead to Ely Lilly's cheaper biosimilar drug Basaglar from 2017.




Weathering the Coming Storm




Price R399.00





Dr. Chuck Missler, an internationally known business executive, outlines our current economic predicament and defensive steps you can take to lessen the impact of the impending economic crisis. As a Bible teacher for over 30 years with a ministry reaching over 40 countries, Chuck shares some key strategies to prepare yourself spiritually and practically.

Is the World facing another major economic upheaval?

What is the best strategy to protect your family in times of economic uncertainty?

The Church has enjoyed a relatively peaceful existence in the West for a few centuries but the with the coming persecution, how do we go about organizing home study and home-church?

Soul Survival – Keeping your “lamp full” during the hard times ahead.

Join Dr. Chuck Missler and Ron Matsen in the Executive Brie fing Room of
The River Lodge, New Zealand, in an intensive summary outlining what lies
ahead and how we can prepare for the coming storm.

Runtime: Approx. 5 hours

© 2012 Koinonia House Inc.

Available in the following formats:



•3 Disks
•5 M4A Files
•1 PDF Notes File
•Color, 16:9, Dolby Digital 2.0 stereo, Region encoding (This DVD will be viewable in other countries WITH the proper DVD player and television set.)



 of the




Dr. Chuck Missler and Ron Matsen


Price R 499.00


There are many diverse anticipations concerning the Coming World Leader, commonly referred to as “The Antichrist.” This study will explore the Biblical descriptions with the specific expectations of the globalists, Islam, the Vatican, Freemasonry, and others.
• Will he be a Nephilim?
• Why is the Vatican openly preparing to receive an “alien” visitor?
• Will he be a resurrection of Nimrod? Is his DNA a factor?
• What are the expectations of transhumanist technologists in this regard?
Clearly, the Bible has much more to illuminate this issue far beyond the popular conceptions; and yet the composite perspective will astonish most. Furthermore, is there a climactic cosmic deception being prepared that, if it were possible, “it would deceive the very elect”? Jesus commanded us, “Be not deceived.” But, how?
How close are these events to our current horizon?
Join Dr. Chuck Missler and Ron Matsen in an intensive summary of some of the Strategic Trends that will impact all of us.
Available in the following formats:

•3 Discs
•6 M4A Files
•1 PDF Notes File
•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  encoding ( This DVD will be viewable in other countries WITH the proper DVD player and television set.)




Feed image







Genetically Modified Food & People.




 Angels, Volume III:

The Denizens of the Metacosm





Price R 179.00


Angels, Volume III: The Denizens of the Metacosm



by Dr. Chuck Missler



Volumes 1 & 2 of this series explored the finite limits and boundaries of our physical reality. After probing the limits of both the Macrocosm and the Microcosm, we discovered that our reality is but a shadow of larger reality, the Metacosm, a domain of extra-dimensional transfers and other paradoxical phenomena.


Volume 3 explores the contradictory behavior of UFOs and other demonic deceptions characteristic of the End Times. Explore these topics in more detail in either this two-hour briefing, Angels Vol 3: The Denizens of the Metacosm or our six-hour extensive study, Expectations of the Antichrist.



• Are they real?

• Why do UFOs enjoy a military classification higher than our most sensitive weapons systems?

• Why are the events which occurred in Roswell New Mexico still classified after 66 years?

• Why is the Vatican openly preparing to receive an Alien Visitor?

• How should a Christian deal with the occurrences of Alien abductions?

• Jesus admonished us to “Be not deceived.” How?

• How do we prepare for the deception which, “if it were possible, would deceive the very elect”?


Join Dr. Chuck Missler in the Executive Briefing Room of the River Lodge, New Zealand, exploring the misinformation, (and deliberate disinformation) about the various “denizens of the Metacosm” and other insights of the invisible war unfolding on our near horizon.


This briefing pack contains 2 hours of teaching


Available in the following formats



•1 Disc

•2 M4A Files

•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region. This DVD will be viewable in other countries WITH the proper DVD player and television set.)



PRICE  R 159.00


PRICE R 159.00



Price  R 159.00



Price R 159.00













Global Events Disaster Site

Extreme Weather, Epidemic, Terror Attack, Biological Hazard,

Volcano Eruption, Earthquake, Incidents at Sea



"In seasons of severe trial, the Christian has nothing on earth that he can trust to, and is therefore compelled to cast himself on God alone. When no human deliverance can avail, he must simply and entirely trust himself to the providence and care of God. Happy storm that wrecks a man on such a rock as this! O blessed hurricane that drives the soul to God--and God alone!"
- Spurgeon





+27 11 969 0086


















Featured Commentaries

Learn the Bible

 in 24 hours

Old Testament






Joshua and The Twelve Tribes


Ruth and Esther

I and II Samuel

I and II Kings

I and II Chronicles

Ezra & Nehemiah





Song of Songs







Joel and Amos

Jonah, Nahum & Obadiah



The Minor



New Testament







I & II Corinthians




Colossians and Philemon

I and II






I and II Peter

I, II, and III John